Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2005 1
2006 2
2007 1
2008 2
2010 1
2011 1
2013 4
2014 2
2015 2
2016 4
2017 3
2018 1
2019 7
2020 5
2021 10
2022 11
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Breast-to-brain metastasis is exacerbated with chemotherapy through blood-cerebrospinal fluid barrier and induces Alzheimer's-like pathology.
Saatian B, Deshpande K, Herrera R, Sedighi S, Eisenbarth R, Iyer M, Das D, Julian A, Martirosian V, Lowman A, LaViolette P, Remsik J, Boire A, Sankey E, Fecci PE, Shiroishi MS, Chow F, Hurth K, Neman J. Saatian B, et al. J Neurosci Res. 2023 Dec;101(12):1900-1913. doi: 10.1002/jnr.25249. Epub 2023 Oct 3. J Neurosci Res. 2023. PMID: 37787045
Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study.
STARSurg Collaborative and TASMAN Collaborative. STARSurg Collaborative and TASMAN Collaborative. Lancet Digit Health. 2022 Jul;4(7):e520-e531. doi: 10.1016/S2589-7500(22)00069-3. Lancet Digit Health. 2022. PMID: 35750401 Free article.
Data from 11 591 patients were available, with an overall postoperative pulmonary complication rate of 7.8% (n=903). None of the six models showed good discrimination (defined as AUROCC 0.70) for identifying postoperative pulmonary complications, with the Assess Respirator …
Data from 11 591 patients were available, with an overall postoperative pulmonary complication rate of 7.8% (n=903). None of the six …
Mitochondrial membranes modify mutant huntingtin aggregation.
Adegbuyiro A, Sedighi F, Jain P, Pinti MV, Siriwardhana C, Hollander JM, Legleiter J. Adegbuyiro A, et al. Biochim Biophys Acta Biomembr. 2021 Oct 1;1863(10):183663. doi: 10.1016/j.bbamem.2021.183663. Epub 2021 Jun 2. Biochim Biophys Acta Biomembr. 2021. PMID: 34089719 Free PMC article.
Huntington's disease (HD) is a neurodegenerative disease caused by the expansion of a polyglutamine (polyQ) tract near the N-terminus of the huntingtin (htt) protein. Expanded polyQ tracts are prone to aggregate into oligomers and insoluble fibrils. ...
Huntington's disease (HD) is a neurodegenerative disease caused by the expansion of a polyglutamine (polyQ) tract near the N-terminus …
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
Sorger H, Dey S, Vieyra-Garcia PA, Pölöske D, Teufelberger AR, de Araujo ED, Sedighi A, Graf R, Spiegl B, Lazzeri I, Braun T, Garces de Los Fayos Alonso I, Schlederer M, Timelthaler G, Kodajova P, Pirker C, Surbek M, Machtinger M, Graier T, Perchthaler I, Pan Y, Fink-Puches R, Cerroni L, Ober J, Otte M, Albrecht JD, Tin G, Abdeldayem A, Manaswiyoungkul P, Olaoye OO, Metzelder ML, Orlova A, Berger W, Wobser M, Nicolay JP, André F, Nguyen VA, Neubauer HA, Fleck R, Merkel O, Herling M, Heitzer E, Gunning PT, Kenner L, Moriggl R, Wolf P. Sorger H, et al. EMBO Mol Med. 2022 Dec 7;14(12):e15200. doi: 10.15252/emmm.202115200. Epub 2022 Nov 7. EMBO Mol Med. 2022. PMID: 36341492 Free PMC article.
We detected copy number gains of loci containing the STAT3/5 oncogenes in 74% (n = 17/23) of L-CTCL, which correlated with the increased clonal T-cell count in the blood. ...
We detected copy number gains of loci containing the STAT3/5 oncogenes in 74% (n = 17/23) of L-CTCL, which correlated with the increa …
Errors in Diagnosing Infectious Diseases: A Physician Survey.
Haddad M, Sheybani F, Naderi H, Sasan MS, Najaf Najafi M, Sedighi M, Seddigh A. Haddad M, et al. Front Med (Lausanne). 2021 Nov 17;8:779454. doi: 10.3389/fmed.2021.779454. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34869499 Free PMC article.
The most common infectious diseases affected by diagnostic errors were upper respiratory tract infections (URTIs) (n = 69, 14.8%), tuberculosis (TB) (n = 66, 14.1%), pleuro-pulmonary infections (n = 54, 11.6%), central nervous system (CNS) infections (n …
The most common infectious diseases affected by diagnostic errors were upper respiratory tract infections (URTIs) (n = 69, 14.8%), tu …
Evaluation of cardiac findings in mucopolysaccharidosis.
Dehghan B, Rostampour N, Sedighi M, Saryazdi MH, Rizi MJ, Mostofizadeh N, Hashemipour M, Khoshhali M. Dehghan B, et al. Int J Cardiovasc Imaging. 2024 Jan;40(1):73-78. doi: 10.1007/s10554-023-02983-y. Epub 2023 Oct 17. Int J Cardiovasc Imaging. 2024. PMID: 37845409
Investigations of adsorption behavior and anti-inflammatory activity of glycine functionalized Al(12)N(12) and Al(12)ON(11) fullerene-like cages.
Aghaei M, Ramezanitaghartapeh M, Javan M, Hoseininezhad-Namin MS, Mirzaei H, Rad AS, Soltani A, Sedighi S, Lup ANK, Khori V, Mahon PJ, Heidari F. Aghaei M, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 5;246:119023. doi: 10.1016/j.saa.2020.119023. Epub 2020 Oct 3. Spectrochim Acta A Mol Biomol Spectrosc. 2021. PMID: 33049473
The adsorption behavior of the amino acid, glycine (Gly), via the carboxyl, hydroxyl, and amino groups onto the surfaces of Al(12)N(12) and Al(16)N(16) fullerene-like cages were computationally evaluated by the combination of density functional theory (DFT) and mole …
The adsorption behavior of the amino acid, glycine (Gly), via the carboxyl, hydroxyl, and amino groups onto the surfaces of Al(12)N(1 …
A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
Taher A, Lashgari M, Sedighi L, Rahimi-Bashar F, Poorolajal J, Mehrpooya M. Taher A, et al. Pharmacol Rep. 2021 Dec;73(6):1650-1659. doi: 10.1007/s43440-021-00296-2. Epub 2021 Jun 10. Pharmacol Rep. 2021. PMID: 34114174 Free PMC article. Clinical Trial.
BACKGROUND: We designed this single-centre clinical trial to assess the potential benefits of N-Acetylcysteine (NAC) in patients with COVID19-associated acute respiratory distress syndrome (ARDS). ...
BACKGROUND: We designed this single-centre clinical trial to assess the potential benefits of N-Acetylcysteine (NAC) in patients with …
66 results